Showing results (151-160 of 386) with videos related to

Sort By:
Pageof 39
Annals of the New York Academy of Sciences|June 19, 2013
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanomaJedd D Wolchok, F Stephen Hodi, Jeffrey S Weber, et al.
Cancers|May 14, 2022
Proton Pump Inhibitor Use and Efficacy of Nivolumab and Ipilimumab in Advanced MelanomaKrisztian Homicsko, Reinhard Dummer, Christoph Hoeller, et al.
Journal for Immunotherapy of Cancer|August 29, 2024
Nivolumab maintenance improves overall survival of patients with advanced melanoma who experience severe immune-related adverse events on nivolumab plus ipilimumabAnna K Maloney, Anita Giobbie-Hurder, Nikita Katukota, et al.
JCI Insight|June 3, 2020
Activation of CAR and non-CAR T cells within the tumor microenvironment following CAR T cell therapyPei-Hsuan Chen, Mikel Lipschitz, Jason L Weirather, et al.
British Journal of Cancer|September 12, 2018
Antitumour activity of pembrolizumab in advanced mucosal melanoma: a post-hoc analysis of KEYNOTE-001, 002, 006Omid Hamid, Caroline Robert, Antoni Ribas, et al.
Biochemical and Biophysical Research Communications|October 28, 2010
Isolation of tumorigenic circulating melanoma cellsJie Ma, Jennifer Y Lin, Allireza Alloo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 17, 2015
Expression of PD-1 and Its Ligands, PD-L1 and PD-L2, in Smokers and Never Smokers with KRAS-Mutant Lung CancerAntonio Calles, Xiaoyun Liao, Lynette M Sholl, et al.
Cancer Research Communications|December 20, 2023
Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I StudyPamela Munster, Nicholas Iannotti, Daniel C Cho, et al.
Melanoma Research|March 11, 2026
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanomaAhmad A Tarhini, Mohammad Ali Khaksar, Zhihua Chen, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanomaAhmad A Tarhini, Mohammad Ali Khaksar, Zhihua Chen, et al.
Pageof 39